UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

UCLA Rheumatology


30th Pearson Symposium


The 30th Carl M Pearson Symposium, held in Marina Del Rey Marriott on April 27th - 29th attracted over 150 attendees across the Southern California community including rheumatologists, interested physicians health care professionals and rheumatology fellows.   The conference focused on most the current information and insights on treatment of rheumatic diseases including Myositis, Rheumatoid Arthritis, Lupus, Pain Management and Scleroderma.

 Key points in this year's conference:

 Dr Moreland emphasized the need to  follow pts quantitatively, while , at least from his point of view, pointing out that acute phase reactants may not be  the only or best way to follow RA pts. He seemed to favor  the CDAI or some measure not requiring laboratory data.

 He also reviewed the newer molecules including tyrosine kinase inhibitors and anti-IL-17 for the  future treatment of RA.

 Dr Crofford concentrated on pain , its understanding and treatment. She  pointed out the important contribution of central pathways to pain and the importance of treating that aspect of pain, rather than only peripheral or  anatomic causes of pain. She made an excellent case for  using narcotics cautiously when treating fibromyalgia, while also emphasizing that there are other medications and treatments that are often effective.

 Dr Dore gave an excellent presentation about the expectations and chaloenges when converting one's practice to an electronic format. There are advantages, clear problems and multiple approaches. In the end, like it or not, she said, some form of electronic health/medical record will need to be used and the earlier the switch is made, the better.

 Dr Hahn ,ever the supurb lecturer,  discussed the real issues and potential approaches to pregnancy in SLE patients as well as  filling the audience in on drugs which may become available in SLE in the future.

 Dr Motamedi( check spelling) gave an excellent review of the usefulness and  differential diagnosis of imaging modalities in selected rheumatic syndromes. His imaging quiz was, as usual, a real time for clinical pearls and  good fun( with prizes!).

 The  "thieve's market " of clinical cases was well attended, despite it being Sunday morning and a "new" disease, IgG4 -related disease, was hi-lited.  

 Over-all, the 151 participants in this year's 3oth Frontiers in Rheumatology seemed to truly enjoy the learning and comaradarie associated with this outhern California institution.


UCLA Rated One of the Top Hospitals in the Nation